These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
299 related items for PubMed ID: 8640754
1. Glutathione conjugates of tert-butyl-hydroquinone, a metabolite of the urinary tract tumor promoter 3-tert-butyl-hydroxyanisole, are toxic to kidney and bladder. Peters MM, Rivera MI, Jones TW, Monks TJ, Lau SS. Cancer Res; 1996 Mar 01; 56(5):1006-11. PubMed ID: 8640754 [Abstract] [Full Text] [Related]
2. Metabolism of tert-butylhydroquinone to S-substituted conjugates in the male Fischer 344 rat. Peters MM, Lau SS, Dulik D, Murphy D, van Ommen B, van Bladeren PJ, Monks TJ. Chem Res Toxicol; 1996 Mar 01; 9(1):133-9. PubMed ID: 8924582 [Abstract] [Full Text] [Related]
3. Identification and structure characterization of S-containing metabolites of 3-tert-butyl-4-hydroxyanisole in rat urine and liver microsomes. Tajima K, Hashizaki M, Yamamoto K, Mizutani T. Drug Metab Dispos; 1991 Mar 01; 19(6):1028-33. PubMed ID: 1687007 [Abstract] [Full Text] [Related]
4. 2-Bromo-(diglutathion-S-yl)hydroquinone nephrotoxicity: physiological, biochemical, and electrochemical determinants. Monks TJ, Highet RJ, Lau SS. Mol Pharmacol; 1988 Oct 01; 34(4):492-500. PubMed ID: 3173333 [Abstract] [Full Text] [Related]
5. Cytotoxicity and cell-proliferation induced by the nephrocarcinogen hydroquinone and its nephrotoxic metabolite 2,3,5-(tris-glutathion-S-yl)hydroquinone. Peters MM, Jones TW, Monks TJ, Lau SS. Carcinogenesis; 1997 Dec 01; 18(12):2393-401. PubMed ID: 9450487 [Abstract] [Full Text] [Related]
6. Metabolism and toxicity of 2-bromo-(diglutathion-S-yl)-hydroquinone and 2-bromo-3-(glutathion-S-yl)hydroquinone in the in situ perfused rat kidney. Rivera MI, Hinojosa LM, Hill BA, Lau SS, Monks TJ. Drug Metab Dispos; 1994 Dec 01; 22(4):503-10. PubMed ID: 7956722 [Abstract] [Full Text] [Related]
7. Metabolism of 2-(glutathion-S-yl)hydroquinone and 2,3,5- (triglutathion-S-yl)hydroquinone in the in situ perfused rat kidney: relationship to nephrotoxicity. Hill BA, Davison KL, Dulik DM, Monks TJ, Lau SS. Toxicol Appl Pharmacol; 1994 Nov 01; 129(1):121-32. PubMed ID: 7974485 [Abstract] [Full Text] [Related]
8. Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity: an in vitro study using rat and human renal proximal tubular cells. Carvalho M, Hawksworth G, Milhazes N, Borges F, Monks TJ, Fernandes E, Carvalho F, Bastos ML. Arch Toxicol; 2002 Oct 01; 76(10):581-8. PubMed ID: 12373454 [Abstract] [Full Text] [Related]
9. Quinone thioether-mediated DNA damage, growth arrest, and gadd153 expression in renal proximal tubular epithelial cells. Jeong JK, Stevens JL, Lau SS, Monks TJ. Mol Pharmacol; 1996 Sep 01; 50(3):592-8. PubMed ID: 8794898 [Abstract] [Full Text] [Related]
10. Modulation of quinol/quinone-thioether toxicity by intramolecular detoxication. Monks TJ. Drug Metab Rev; 1995 Sep 01; 27(1-2):93-106. PubMed ID: 7641587 [Abstract] [Full Text] [Related]
11. Inhibition of gamma-glutamyl transpeptidase potentiates the nephrotoxicity of glutathione-conjugated chlorohydroquinones. Mertens JJ, Temmink JH, van Bladeren PJ, Jones TW, Lo HH, Lau SS, Monks TJ. Toxicol Appl Pharmacol; 1991 Aug 01; 110(1):45-60. PubMed ID: 1678558 [Abstract] [Full Text] [Related]
12. Metabolism of 3-tert-butyl-4-hydroxyanisole by microsomal fractions and isolated rat hepatocytes. Cummings SW, Ansari GA, Guengerich FP, Crouch LS, Prough RA. Cancer Res; 1985 Nov 01; 45(11 Pt 2):5617-24. PubMed ID: 4053035 [Abstract] [Full Text] [Related]
13. The in vivo disposition of 2-bromo-[14C]hydroquinone and the effect of gamma-glutamyl transpeptidase inhibition. Lau SS, Monks TJ. Toxicol Appl Pharmacol; 1990 Mar 15; 103(1):121-32. PubMed ID: 1969181 [Abstract] [Full Text] [Related]
14. Identification of multi-S-substituted conjugates of hydroquinone by HPLC-coulometric electrode array analysis and mass spectroscopy. Hill BA, Kleiner HE, Ryan EA, Dulik DM, Monks TJ, Lau SS. Chem Res Toxicol; 1993 Mar 15; 6(4):459-69. PubMed ID: 8374043 [Abstract] [Full Text] [Related]
15. Metabolism as a determinant of species susceptibility to 2,3,5-(triglutathion-S-yl)hydroquinone-mediated nephrotoxicity. The role of N-acetylation and N-deacetylation. Lau SS, Kleiner HE, Monks TJ. Drug Metab Dispos; 1995 Oct 15; 23(10):1136-42. PubMed ID: 8654203 [Abstract] [Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of t-Butylhydroquinone (CAS No. 1948-33-0) in F344/N Rats and B6C3F(1) Mice (Feed Studies). National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1997 May 15; 459():1-326. PubMed ID: 12587017 [Abstract] [Full Text] [Related]
17. Estimated daily intakes of butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT) and tert-butyl hydroquinone (TBHQ) antioxidants in Korea. Suh HJ, Chung MS, Cho YH, Kim JW, Kim DH, Han KW, Kim CJ. Food Addit Contam; 2005 Dec 15; 22(12):1176-88. PubMed ID: 16356880 [Abstract] [Full Text] [Related]
18. The effect of oxygen tension on the cytotoxicity of hydroquinone and selected hydroquinone metabolites to isolated rat renal proximal tubular cells. Boatman RJ, English JC, Guerin TS, Cummings LM. Arch Toxicol; 2004 Aug 15; 78(8):443-52. PubMed ID: 15083269 [Abstract] [Full Text] [Related]
19. DNA damage, gadd153 expression, and cytotoxicity in plateau-phase renal proximal tubular epithelial cells treated with a quinol thioether. Jeong JK, Dybing E, Søderlund E, Brunborg G, Holme JA, Lau SS, Monks TJ. Arch Biochem Biophys; 1997 May 15; 341(2):300-8. PubMed ID: 9169019 [Abstract] [Full Text] [Related]
20. Developmental toxicity of bromohydroquinone (BHQ) and BHQ-glutathione conjugates in vivo and in whole embryo culture. Andrews JE, Rogers JM, Ebron-McCoy M, Logsdon TR, Monks TJ, Lau SS. Toxicol Appl Pharmacol; 1993 May 15; 120(1):1-7. PubMed ID: 8099763 [Abstract] [Full Text] [Related] Page: [Next] [New Search]